FindMyKOL
Clinical trialNCT05752032Active, not recruitingObservational

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

NCT05752032 is an observational study sponsored by ICM Co. Ltd.. As of 21 Nov 2026, it is active and no longer recruiting. It studies Placebo in Osteoarthritis, Knee. The registry lists an enrollment of 10 participants at 2 sites in 1 country. The registry lists a start date of 16 Mar 2023 and a primary completion date of 31 Jul 2029.

SponsorICM Co. Ltd.Enrollment10Osteoarthritis, Knee
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05752032
FieldValue
Registry IDNCT05752032
StatusActive not recruiting
Study typeObservational study
Lead sponsorICM Co. Ltd.
Enrollment10
Registered sites2
Countries1
ConditionsOsteoarthritis, Knee
DrugsPlacebo
Start16 Mar 2023
Primary completion31 Jul 2029
Study completion31 Jul 2029
Last update posted3 Sept 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an observational study of the long term safety and efficacy of ICM-203.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia2 sites
  • Royal Adelaide Hospital

    Adelaide, South Australia

  • Barwon Health

    Geelong, Victoria

Sites by country

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT05752032

Each answer restates registry values shown on this page.

What is NCT05752032?

NCT05752032 is an observational study sponsored by ICM Co. Ltd.. It studies Placebo in Osteoarthritis, Knee.

Is NCT05752032 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT05752032?

The registry names Alison Heald, MD (study director, ICM Co. Ltd.) as the overall official.

Where does NCT05752032 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: Australia.

Which drugs does NCT05752032 study?

The registered drug and biological interventions are Placebo.

When is NCT05752032 expected to complete?

The registry lists a primary completion date of 31 Jul 2029 and a study completion date of 31 Jul 2029. The sponsor last updated the record on 3 Sept 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.